Übersicht der wichtigsten Publikationen

 Prof. Dr. med. H. Goldschmidt (Stand: 20.11.13)

 

Buchveröffentlichungen

 

Moehler T., Goldschmidt, H. (Eds.) Multiple Myeloma, Series: Recent Results in Cancer Research, Vol.183, Schlag, P.M., Senn H.-J. (Managing Eds.), Springer-Verlag Berlin Heidelberg 2011


Peest, D., Goldschmidt, H. Multiples Myelom. Deutscher Ärzte-Verlag Köln 2011


Goldschmidt, H. Das Multiple Myelom (Plasmozytom) – Diagnose und Therapie. Überarbeitete Neuauflage, Uni-Med Verlag AG, Bremen, London, Boston 2011       

 

Publikationen


Hose, D., Reme, T., Meissner, T., Moreaux, J., Seckinger, A., Lewis, J., Benes, V., Benner, A., Hundemer, M., Hielscher, T., Shaughnessy, J.D. Jr, Barlogie, B., Neben, K., Kramer, A., Hillengass, J., Bertsch, U., Jauch, A., De Vos, J., Rossi, J.F., Moehler, T., Blake, J., Zimmermann, J., Klein, B., Goldschmidt H. (2009) Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma. Blood. 113, 4331-4340

Hillengass, J., Fechtner, K., Weber, M.-A., Bäuerle, T., Ayyaz, S., Heiss, C., Hielscher, T., Moehler, T., Egerer, G., Neben, K., Ho, A., Kauczor, U., Delorme, S., Goldschmidt, H. (2010) Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol. 28, 1606-1610

Neben, K., Jauch, A., Bertsch, U., Heiss, C., Hielscher, T., Seckinger, A., Mors, T., Müller, N.Z., Hillengass, J., Raab, M.S., Ho, A.D., Hose, D., Goldschmidt, H. (2010) Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation. Haematologica. 95, 1150-1157

Neben K, Lokhorst HM, Jauch A, Bertsch U, Hielscher T, van der Holt B, Salwender H, Blau IW, Weisel K, Pfreundschuh M, Scheid C, Dührsen U, Lindemann W, Schmidt-Wolf IG, Peter N, Teschendorf C, Martin H, Haenel M, Derigs HG, Raab MS, Ho AD, van de Velde H, Hose D, Sonneveld P, Goldschmidt H. Administration of bortezomib before and after autologous stem-cell transplantation improves outcome in multiple myeloma patients with deletion 17p. Blood. 119(4), 940-8 (2012)

Sonneveld P, Schmidt-Wolf I, van der Holt B, el Jarari L, Bertsch U, Salwender H, Zweegman S, Vellenga E, Broyl A, Blau IW, Weisel KC, Wittebol S, Bos G, Stevens-Kroef M, Scheid C, Pfeundschuh M, Hose D, Jauch A, van der Velde H, Raymakers R, Schaafsma MR, Kersten MJ,  van Marwijk Kooy M, Duehrsen U, Lindemann W, Wijermans PW,  Lokhorst H, Goldschmidt H. Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase 3 HOVON-65/GMMG-HD4 trial. . J Clin Oncol 30(24):2946-55 (2012)

Weinhold, N., Johnson, D.C., Chubb, D., Chen, B., Försti, A., Hosking, F.J., Broderick, P., Ma, Y.P., Dobbins, S.E., Hose, D., Walker, B.A., Davies, F.E., Kaiser, M.F., Li, N.L., Gregory, W.A., Jackson, G.H., Witzens-Harig, M., Neben, K., Hoffmann, P., Nöthen, M.M., Mühleisen, T.W., Eisele, L., Ross, F.M., Jauch, A., Goldschmidt, H., Houlston, R.S., Morgan, G.J., Hemminki, K. (2013) The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat Genet. 45(5):522-5

Sonneveld, P., Goldschmidt, H., Rosiñol, L., Bladé, J., Lahuerta, J.J., Cavo, M., Tacchetti, P., Zamagni, E., Attal, M., Lokhorst, H.M., Desai, A., Cakana, A., Liu, K., van de Velde, H., Esseltine, D.L., Moreau, P. Bortezomib-Based Versus Nonbortezomib-Based Induction Treatment Before Autologous Stem-Cell Transplantation in Patients With Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials. J Clin Oncol. 31(26):3279-3287 2013)

Chubb, D., Weinhold, N., Broderick, P., Chen, B., Johnson, D.C., Försti, A., Vijayakrishnan, J., Migliorini, G., Dobbins, S.E., Holroyd, A., Hose, D., Walker, B.A., Davies, F.E., Gregory, W.A., Jackson, G.H., Irving, J.A., Pratt, G., Fegan, C., Fenton, J.A., Neben, K., Hoffmann, P., Nöthen, M.M., Mühleisen, T.W., Eisele, L., Ross, F.M., Straka, C., Einsele, H., Langer, C., Dörner, E., Allan, J.M., Jauch, A., Morgan, G.J., Hemminki, K., Houlston, R.S., Goldschmidt, H. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet. 2013 Aug 18. [Epub ahead of print]

Hillengass, J., Weber, M.A., Kilk, K., Listl, K., Wagner-Gund, B., Hillengass, M., Hielscher, T., Farid, A., Neben, K., Delorme, S., Landgren, O., Goldschmidt, H. Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance. Leukemia. 2013 Aug 20. [Epub ahead of print]


 

 

Print Diese Seite per E-Mail weiterempfehlen